Literature DB >> 26872512

Early-stage hip involvement in patients with ankylosing spondylitis: A Chinese study based on magnetic resonance imaging.

Dongying Chen1, Shiwen Yuan2, Zhongping Zhan1, Youjun Xiao1, Hao Li1, Liuqin Liang1, Xiuyan Yang1.   

Abstract

OBJECTIVES: To evaluate the clinical characteristics and identify potential factors of the early-stage hip involvement in patients with ankylosing spondylitis (AS) based on the magnetic resonance imaging (MRI).
METHODS: A cross-sectional retrospective study of 655 consecutive patients was performed. Patients with hip pain or limited hip function but lacking definitive evidence of hip involvement on radiography underwent hip MRI. Based on the results of the imaging tests, the patients were classified into three categories: (1) no hip involvement; (2) early-stage hip involvement according to MRI but not radiography; (3) advanced-stage hip involvement according to a Bath Ankylosing Spondylitis Radiology Index-hip score ≥2.
RESULTS: One hundred and sixty-eight patients had early-stage hip involvement and 103 patients had advanced-stage hip involvement. Multivariate logistic regression analysis indicated that younger age at onset, worse BASMI score, and more active inflammation in the sacroiliac joints were associated with the occurrence of early-stage hip involvement.
CONCLUSION: Negative plain radiography results cannot be used to rule out hip involvement. MRI was superior to radiography for the detection of early-stage hip involvement. Susceptible AS patients with symptoms or risk factors for hip involvement should undergo hip MRI to test for lesions in the early stage.

Entities:  

Keywords:  Ankylosing spondylitis; Early stage; Hip involvement; Magnetic resonance imaging

Mesh:

Year:  2016        PMID: 26872512     DOI: 10.3109/14397595.2016.1153232

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  7 in total

1.  An unusual presentation of ankylosing spondylitis.

Authors:  Dinesh Sirisena; Yong-Yeow Chong; Teck-Yew Chin
Journal:  Singapore Med J       Date:  2018-07-16       Impact factor: 1.858

2.  Hip Replacement in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Factors Associated with Bilateral Total Hip Arthroplasty.

Authors:  Liangliang Li; Jun Fu; Chi Xu; Ming Ni; Wei Chai; Libo Hao; Yonggang Zhou; Jiying Chen
Journal:  Int J Gen Med       Date:  2021-10-15

3.  The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study.

Authors:  Kui Zhang; Yan Zheng; Qing Han; Ying Liu; Weitao Wang; Jin Ding; Yan Wang; Bei Zhang; Junfeng Jia; Minwen Zheng; Zhaohui Zheng; Ping Zhu
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

4.  Gender Differences in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Results from A Matched Retrospective Cohort Study.

Authors:  Liang-Liang Li; Jun Fu; Chi Xu; Ming Ni; Wei Chai; Li-Bo Hao; Yong-Gang Zhou; Ji-Ying Chen
Journal:  Orthop Surg       Date:  2021-12-13       Impact factor: 2.071

5.  Fourth-Generation Ceramic-on-Ceramic THA in Patients with Ankylosing Spondylitis: A Minimum 10-Year Follow-Up.

Authors:  Liangliang Li; Jun Fu; Chi Xu; Ming Ni; Wei Chai; Libo Hao; Yonggang Zhou; Jiying Chen
Journal:  Orthop Surg       Date:  2022-04-18       Impact factor: 2.279

6.  Factors associated with blood loss in ankylosing spondylitis patients with hip involvement undergoing primary total hip arthroplasty: a cross-sectional retrospective study of 243 patients.

Authors:  Liangliang Li; Jun Fu; Chi Xu; Haitao Guan; Ming Ni; Wei Chai; Libo Hao; Yonggang Zhou; Jiying Chen
Journal:  J Orthop Surg Res       Date:  2020-11-18       Impact factor: 2.359

7.  Early stage Acute B lymphocytic leukemia presenting with symptoms of ankylosing spondylitis (AS): A case report.

Authors:  Wei Liu; Guangfeng Chen; Bing Xu; Suping Sun; Jingzhen Tian; Yingying Zhang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.